The landscape of dementia prognosis has advanced dramatically with the appearance of subtle biomarkers, including amyloid PET scans, tau imaging, and blood-centered assessments that could detect Alzheimer's pathology several years just before signs and symptoms emerge. Even though these technological developments represent extraordinary development in knowing neurodegenerative illness... https://conanm531mwh1.wiki-promo.com/user